Raptor Pharmaceutical Corp. (NASDAQ: RPTP), a biopharmaceutical company with a focus on ... with up to $34.2 million of the closing consideration payable in common stock plus contingent payments of up to $350 million associated with development …
Benzinga · 8/21/2015
The stock closed Monday's trading at $5.39 ... Raptor Pharmaceutical Corp.'s (RPTP) PROCYSBI has received FDA approval for its expanded use in treating children two to six years of age with nephropathic cystinosis.
Realtime Business News · 8/18/2015
Raptor Pharma (NASDAQ: RPTP) has signed a definitive agreement with Tripex Pharmaceuticals ... with up to $34.2 million of the closing consideration payable in Raptor common stock at Raptor's election plus contingent payments of up to $350 million ...
StreetInsider · 8/20/2015
Some of the biggest gainers among healthcare stocks include: Mannkind Corp (MNKD): MNKD stock is up 3.0% today ... Raptor Pharmaceutical (RPTP): RPTP stock is down 4.2% today. Magellan Health Services (MGLN): MGLN stock is down 3.8% today.
Investor Place · 8/11/2015
Raptor (NASDAQ:RPTP) had an efficacy supplement with clinical data to support ... NYSEMKT- Hemispherx Biopharma was among the most active biotechs on the NYSEMKT. The stock closed 3.83% lower. OTC- Anavex Life Sciences (OTCQX:AVXL) …
Seeking Alpha · 8/18/2015
Medical Marijuana
NOVATO, Calif., Aug. 20, 2015 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) announced today that it was named among the top workplaces in the North Bay in the 10th Annual North Bay Business Journal competition. The results …
Financial Content · 8/20/2015
North Bay
Oppenheimer reiterated their underperform rating on shares of Raptor Pharmaceutical Corp. (NASDAQ:RPTP) in a research report released on Monday, reports. The brokerage currently has a $8.00 price objective on the stock. In other Raptor ...
Mideast Times · 8/15/2015
The company again lifted its outlook for 2016, sending its shares up 5 percent in after-hours trade on the New York Stock Exchange. weiterlesen ... Mitteilung von WASHINGTON - Raptor Pharmaceutical Corp (RPTP) on Thursday said it …
AD HOC News · 8/21/2015
Raptor Pharmaceutical Corp. (RPTP) was among the biggest gainers on the Russell 2000 for Friday August 21 as the stock popped 5.82% to $12.72, representing a gain of $0.7 per share. Some 2.34 million shares traded hands on 15,830 trades, compared …
Equities · 8/21/2015
Raptor Pharmaceutical Corp. (RPTP) is beefing up its rare disease portfolio with the ... News of the acquisition was received positively at the opening bell of the NASDAQ this morning. The stock was up more than 3 … · 8/20/2015
cystic fibrosis